CSRC/DIA: Social Listening and Safety Surveillance—Enabling Opportunities for Cardiac Safety

FDA - White Oak Campus - Meeting Room

Cost, Value, and Patient Outcomes: The Growing Need for Payer Engagement

By Gregory W. Daniel, PhD, MPH, RPh and Morgan H. Romine Found in: Pricing / Reimbursement, Public Policy / Law, Article, Clinical Supplies, Clinical Safety & Pharmacovigilance

Since passage of the Affordable Care Act in 2010, the last several years have seen a groundswell in physician payment and delivery reforms designed to achieve higher value health care through incentivizing higher quality care and lower overall costs.

DIA Webinar To Discuss How Technology and Collaboration Can Reinvent the Clinical Trial

Found in: Article, Clinical Research, Clinical Supplies, Clinical Safety & Pharmacovigilance, CMC

Many sponsor organizations are wrestling with how to improve the monitoring process with technology in an industry still fresh from the shackles of traditional paper-based data handling.

How to Prepare for a Safety Inspection

Global Forum Special Section: Social Media @DIA

By Brandon King Found in: Article, Anti-doping, Academic Health Centers, Alternative / Herbal Med, Biotechnology, Clinical Data Management, CMC, Clinical Safety & Pharmacovigilance, Clinical Research, Clinical Supplies, Devices & Diagnostics, Medical Communications, Managed Health, Medical Writing

Social media is essentially like talking to someone, just through your respective computers, iPhones, smart devices or other electronic or digital tool.

Global Forum Special Section: Orphan Drugs in the 21st Century

By Chris M. Slawecki Found in: Article, Clinical Safety & Pharmacovigilance, Clinical Research, Rare, Orphan Diseases

The US National Institutes of Health estimate that there are approximately 6,000 rare diseases affecting 25 million Americans. EURORDIS, the Voice of Rare Disease Patients in Europe, estimates the number of persons in Europe suffering from a rare disease at more than 30 million. Many of these conditions have no current treatment.

DIA 2016

Pennsylvania Convention Center

DIA Latin America Regulatory Conference (LARC) 2016

Pennsylvania Convention Center
Global Forum

Cost, Value, and Patient Outcomes: The Growing Need for Payer Engagement

By Gregory W. Daniel, PhD, MPH, RPh and Morgan H. Romine Found in: Pricing / Reimbursement, Public Policy / Law, Article, Clinical Supplies, Clinical Safety & Pharmacovigilance

Since passage of the Affordable Care Act in 2010, the last several years have seen a groundswell in physician payment and delivery reforms designed to achieve higher value health care through incentivizing higher quality care and lower overall costs.

Global Forum Special Section: Social Media @DIA

By Brandon King Found in: Article, Anti-doping, Academic Health Centers, Alternative / Herbal Med, Biotechnology, Clinical Data Management, CMC, Clinical Safety & Pharmacovigilance, Clinical Research, Clinical Supplies, Devices & Diagnostics, Medical Communications, Managed Health, Medical Writing

Social media is essentially like talking to someone, just through your respective computers, iPhones, smart devices or other electronic or digital tool.

Global Forum Special Section: Orphan Drugs in the 21st Century

By Chris M. Slawecki Found in: Article, Clinical Safety & Pharmacovigilance, Clinical Research, Rare, Orphan Diseases

The US National Institutes of Health estimate that there are approximately 6,000 rare diseases affecting 25 million Americans. EURORDIS, the Voice of Rare Disease Patients in Europe, estimates the number of persons in Europe suffering from a rare disease at more than 30 million. Many of these conditions have no current treatment.

CSRC/DIA: Social Listening and Safety Surveillance—Enabling Opportunities for Cardiac Safety

FDA - White Oak Campus - Meeting Room

How to Prepare for a Safety Inspection

DIA 2016

Pennsylvania Convention Center

DIA Latin America Regulatory Conference (LARC) 2016

Pennsylvania Convention Center

#25: Signal Detection: Identifying and Managing Safety Signals

Pennsylvania Convention Center

#40: Analysis of Safety Data from Clinical Trials

Pennsylvania Convention Center

#43: Risk Management and Safety Communication Strategies

Pennsylvania Convention Center

Introduction to Signal Detection and Data Mining

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

The Westin Boston Waterfront

Clinical Statistics for Nonstatisticians

The Westin Boston Waterfront

Clinical Project Management

The Westin Boston Waterfront

New Drug Product Development and Life Cycle Management

The Westin Boston Waterfront

Global Labeling 2016

Omni Shoreham Hotel

Development of a Clinical Study Report

Risk Management and Safety Communication Strategies

DIA Global Center

DIA Annual Canadian Meeting 2016

Ottawa Marriott Hotel

Postmarketing Drug Safety and Pharmacovigilance

Sheraton Philadelphia University City

Biosimilars 2016

Renaissance Washington DC Dupont Circle Hotel

Advancing the Science of Study Endpoints

Omni Shoreham Hotel

Informed Consent

On demand

DIA Webinar To Discuss How Technology and Collaboration Can Reinvent the Clinical Trial

Found in: Article, Clinical Research, Clinical Supplies, Clinical Safety & Pharmacovigilance, CMC

Many sponsor organizations are wrestling with how to improve the monitoring process with technology in an industry still fresh from the shackles of traditional paper-based data handling.